Doctors test Infants' own cells to help failing hearts
NCT ID NCT03406884
Summary
This early-stage study tested the safety and feasibility of injecting a child's own heart stem cells during a planned surgery for hypoplastic left heart syndrome (HLHS). Researchers enrolled 25 infants to see if the cells could be prepared and delivered safely, and to look for early signs of improved heart function, growth, and health outcomes over one year. The main goal was to check for serious side effects and see if the procedure was possible.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOPLASTIC LEFT HEART SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611, United States
-
Emory University Children's Healthcare of Atlanta - Egleston Campus
Atlanta, Georgia, 30322, United States
-
Michigan Medicine Congenital Heart Center/C.S. Mott Children's Hospital
Ann Arbor, Michigan, 48109, United States
-
University of Maryland - Division of Cardiac Surgery
Baltimore, Maryland, 21201, United States
Conditions
Explore the condition pages connected to this study.